Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Intangibles (2020 - 2025)

Arcadia Biosciences' Intangibles history spans 6 years, with the latest figure at $39000.0 for Q4 2025.

  • For Q4 2025, Intangibles changed 0.0% year-over-year to $39000.0; the TTM value through Dec 2025 reached $39000.0, changed 0.0%, while the annual FY2025 figure was $39000.0, 0.0% changed from the prior year.
  • Intangibles reached $39000.0 in Q4 2025 per RKDA's latest filing, roughly flat from $39000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $4.1 million in Q2 2021 to a low of $39000.0 in Q4 2023.
  • Average Intangibles over 5 years is $524000.0, with a median of $40000.0 recorded in 2022.
  • Peak YoY movement for Intangibles: soared 876.25% in 2021, then crashed 96.29% in 2022.
  • A 5-year view of Intangibles shows it stood at $484000.0 in 2021, then crashed by 91.74% to $40000.0 in 2022, then fell by 2.5% to $39000.0 in 2023, then changed by 0.0% to $39000.0 in 2024, then changed by 0.0% to $39000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Intangibles are $39000.0 (Q4 2025), $39000.0 (Q3 2025), and $39000.0 (Q2 2025).